European shares edge higher as US-EU trade talks hopes buoy sentiment
The pan-European STOXX 600 index (.STOXX), opens new tab gained 0.2% to 547.74 points, as of 0711 GMT. Other regional indexes also traded higher.
On Monday, the European Union accused the U.S. of resisting efforts to strike a trade deal and warned of countermeasures if no agreement is reached.
Trump, meanwhile, said he was open to talks with the EU and other trading partners, adding that EU officials would be coming to the U.S. for trade negotiations.
Trump had escalated trade tensions over the weekend, threatening a 30% tariff on most EU imports from August 1.
In the market, auto stocks (.SXAP), opens new tab rose 0.9%, technology stocks (.SX8P), opens new tab advanced 0.8%, while telecoms shares (.SXKP), opens new tab fell 0.8%.
Orsted (ORSTED.CO), opens new tab rose 5.5% after Morgan Stanley raised the Danish offshore wind developer to "Overweight" from "Equal Weight".
On the data front, euro zone industrial production data for May and Germany's ZEW Economic Sentiment for July are due on Tuesday.
In the U.S., earnings season is also set to begin on Tuesday, with second-quarter reports from major banks, while investors also await U.S. consumer price data for June due later in the day.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Reuters
22 minutes ago
- Reuters
Julius Baer's first-half profit falls 35% on loan provisions, Brazil unit sale
July 22 (Reuters) - Swiss bank Julius Baer (BAER.S), opens new tab posted a first-half profit of 295 million francs ($370 million) on Tuesday, down 35% year-on-year, pressured by loan loss provisions and a charge related to the sale of its Brazilian wealth management unit. The decline reflected earlier-flagged writedown of 130 million Swiss francs, the bank said, adding that it made strong progress on legacy issues. "We are now in full execution mode of our strategic agenda, focused on our core wealth management lane, balancing sustainable growth and cost discipline with strengthened risk management," CEO Stefan Bollinger told journalists. To date, the bank had no additional loan loss allowances to report, Bollinger added. "Once the credit review has been completed, we'll be in a position to decide whether or not additional loan loss allowances are required," he said. Net new money more than doubled year-on-year to 7.9 billion Swiss francs, bringing assets under management to 483 billion francs, as of end-June, Julius Baer said in its half-year results presentation. Positive effects of solid net new money and rising global equity market valuations were more than offset by the impact of the weaker U.S. dollar and the sale of Julius Baer Brazil in March 2025, the bank said. The bank is on track to achieve 130 million Swiss francs in additional gross cost savings by the end of 2025, according to the statement. ($1 = 0.7975 Swiss francs)
Reuters
24 minutes ago
- Reuters
Norwegian utility Statkraft books $640 mln Q2 loss after impairments
OSLO, July 22 (Reuters) - Norway's biggest utility, state-owned Statkraft, reported on Tuesday a deeper net loss for the second quarter, driven primarily by impairments due to lower expectations for future power prices. The net loss for the April-June period stood at 6.5 billion Norwegian crowns ($638.56 million), against a year-ago loss of 992 million crowns, its report showed. Statkraft, which has continued this year to scale back its growth ambitions amid rising costs, said on Tuesday it will concentrate on its core competitive advantages and prioritise investments in near-term profitable opportunities. "Given the current market situation and geopolitical realities, combined with Statkraft's recent high activity and investment level, we are adjusting our strategic ambitions," CEO Birgitte Ringstad Vartdal said in a statement. Ratings agency Fitch earlier this month cut Statkraft's credit rating by one notch to BBB+ from A-, citing weakening performance and financial metrics. ($1 = 10.1791 Norwegian crowns)
Reuters
24 minutes ago
- Reuters
France's Sanofi to acquire biotech firm Vicebio for $1.15 billion
July 22 (Reuters) - French pharmaceuticals company Sanofi ( opens new tab said on Tuesday it would acquire British private biotechnology firm Vicebio for a total of $1.15 billion, expanding its respiratory vaccine portfolio. Following the acquisition, Vicebio's non-mRNA candidate vaccine for treating respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) will be added to Sanofi's range. The Vicebio deal includes a potential milestone payment of up to $450 million based on development and research achievements, and is expected to close in the fourth quarter of this year. Sanofi will also obtain "Molecular Clamp" technology aimed at enabling quicker development of fully liquid combination vaccines that can be stored at standard refrigeration temperatures, eliminating the need for freezing or freeze-drying. The British company is the latest in a string of acquisitions by Sanofi, which recently finalised an up to $9.5 billion deal for U.S.-based Blueprint Medicines Corporation. Sanofi said that the acquisition will not impact its annual guidance.
